News for January 2016

Breakthrough in human cell transformation could revolutionise regenerative medicine

A breakthrough in the transformation of human cells, by an international team led by researchers at the University of Bristol, could open the door to a new range of treatments for a variety of medical conditions.
21 January, 2016

The Current issue of “The view from here” presents the four most-downloaded articles of 2015.

The topic of this month’s newsletter from Drug Discovery Today is “The best of 2015”.
20 January, 2016

TSRI Researchers Develop Versatile New Way to Build Molecules

Chemists at The Scripps Research Institute (TSRI) have devised a new and widely applicable technique for building potential drug molecules and other organic compounds.
20 January, 2016

TSRI Chemists Devise Powerful New Method for Modifying Drug Molecules

‘Strain-release amination’ technique emerged from efforts to help Pfizer synthesize promising cancer drug candidate
19 January, 2016

Blueberries, citrus fruits and red wine associated with a reduced risk of developing erectile dysfunction

Flavonoid-rich foods are associated with a reduced risk of erectile dysfunction – according to a new collaborative study from the University of East Anglia (UEA) and Harvard University.
13 January, 2016

A century after Endurance, Shackleton diagnosed with ‘hole in the heart’

On the 100th anniversary of the Endurance expedition to Antarctica led by Sir Ernest Shackleton, doctors writing in the Journal of the Royal Society of Medicine believe the inspirational explorer may have had the congenital defect commonly known as a ‘hole in the heart’. Shackleton was capable of severe exertion and made the first crossing of the mountains and glaciers of South Georgia without any health problems. During other expeditions, however, he alarmed his companions with repeated attacks of breathlessness and weakness.
13 January, 2016

VIB researchers discover possible strategy against stroke

Scientists at VIB and KU Leuven have identified the oxygen sensor PHD1 as a potential target for the treatment of brain infarction (ischemic stroke). Despite (minor) improvements in stroke treatment, stroke remains the fourth leading cause of death and the most common reason of severe disability. The impact of stroke is overwhelming for the patient, family and society –representing one of the largest unmet medical needs. Research led by prof. Peter Carmeliet and dr. Annelies Quaegebeur (VIB/KU Leuven) indicates that inhibition of PHD1 offers protection against stroke, via an unexpected mechanism, raising hope for future stroke treatment.
08 January, 2016

News Archive

Breakthrough in human cell transformation could revolutionise regenerative medicine Breakthrough in human cell transformation could revolutionise regenerative medicine

The Current issue of “The view from here” presents the four most-downloaded articles of 2015. The Current issue of “The view from here” presents the four most-downloaded articles of 2015.

TSRI Researchers Develop Versatile New Way to Build Molecules TSRI Researchers Develop Versatile New Way to Build Molecules

TSRI Chemists Devise Powerful New Method for Modifying Drug Molecules TSRI Chemists Devise Powerful New Method for Modifying Drug Molecules

Blueberries, citrus fruits and red wine associated with a reduced risk of developing erectile dysfunction Blueberries, citrus fruits and red wine associated with a reduced risk of developing erectile dysfunction

A century after Endurance, Shackleton diagnosed with ‘hole in the heart’ A century after Endurance, Shackleton diagnosed with ‘hole in the heart’

VIB researchers discover possible strategy against stroke VIB researchers discover possible strategy against stroke